Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kosuke, Mizusaki"'
Autor:
Takahide Iwasaki, Kosuke Mizusaki, Miwa Masumoto, Yuko Minagawa, Kouta Azuma, Tetsuya Furukawa, Makoto Yoshida, Takahiro Kuragano
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background TAFRO syndrome is an acute or subacute systemic inflammatory disease with no apparent cause, presenting with fever, generalized edema, thrombocytopenia, renal damage, anemia, and organ enlargement. Interleukin-6, vascular endothel
Externí odkaz:
https://doaj.org/article/6fcf7aa7920d4705a91d12d6cce5d2d6
Autor:
Kaoruko Wato, Yasuyuki Nagasawa, Yahiro Mana, Aritoshi Kida, Takahiro Kuragano, Suhei Naka, Masayoshi Nanami, Ryota Nomura, Kazuhiko Nakano, Taro Misaki, Yukiko Hasuike, Michiyo Matsumoto-Nakano, Seigo Ito, Kosuke Mizusaki
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Yukiko Hasuike, Yasuyuki Nagasawa, Takahiro Kuragano, Yahiro Mana, Kosuke Mizusaki, Naoto Kakita, Sataoko Masachika, Masaharu Ishihara, Kida Arithoshi, Tomoko Kimura, Satoshi Kitagawa, Nanami Masayoshi
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Yasuyuki Nagasawa, Kei Onaka, Kazunori Kashiwase, Kazuhiro Kitajima, Yahiro Mana, Aritoshi Kida, Tomoko Kimura, Kosuke Mizusaki, Masayoshi Nanami, Yukiko Hasuike, Takahiro Kuragano, Masanori Asakura, Masaharu Ishihara, Kenichi Hirano
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Takahiro Kuragano, Tomoko Kimura, Yasuyuki Nagasawa, Michio Nojima, Kosuke Mizusaki, Yukiko Hasuike, Takeshi Nakanishi, Shingo Yamamoto, Yusuke Yamada, Masaharu Ishihara
Publikováno v:
Blood purification. 47
Background/Aims: α-Klotho is mainly expressed in the kidneys, and its soluble form can prevent vascular calcifications. Inhibition of the mammalian target of rapamycin (mTOR) upregulates Klotho. We assessed serial changes in the levels of soluble Kl
Autor:
Wataru Fukao, Shoji Kaibe, Yasuyuki Nagasawa, Mai Oue, Takahiro Kuragano, Kosuke Mizusaki, Tomoko Kimura, Yukiko Hasuike, Takeshi Nakanishi, Sayuri Hamahata
Publikováno v:
Therapeutic Apheresis and Dialysis. 18:334-339
Patients with chronic kidney disease on dialysis are at higher risk for cardiovascular disease (CVD), which is the greatest cause of mortality. The target range of serum intact parathyroid hormone (iPTH) for prognosis, 60 to 240 pg/mL, was recommende
Autor:
Yasuyuki Nagasawa, Soshi Yorifuji, Aritoshi Kida, Takahiro Kuragano, Masayoshi Nanami, Wataru Fukao, Takeshi Nakanishi, Yukiko Hasuike, Kosuke Mizusaki, Mana Yahiro
Publikováno v:
Nephrology Dialysis Transplantation. 33:i245-i245
Autor:
Yukiko, Hasuike, Mai, Oue, Sayuri, Hamahata, Tomoko, Kimura, Wataru, Fukao, Kosuke, Mizusaki, Shoji, Kaibe, Yasuyuki, Nagasawa, Takahiro, Kuragano, Takeshi, Nakanishi
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 18(4)
Patients with chronic kidney disease on dialysis are at higher risk for cardiovascular disease (CVD), which is the greatest cause of mortality. The target range of serum intact parathyroid hormone (iPTH) for prognosis, 60 to 240 pg/mL, was recommende
Autor:
Masanori Tokuyama, Wataru Fukao, Satoko Masachika, Rie Kitamura, Takeshi Nakanishi, Soshi Yorifuji, Kosuke Mizusaki, Kazuhiro Toyoda, Mai Oue, Yukiko Hasuike, Keisuke Hiraoka, Mana Yahiro, Ryoichi Yorifuji
Publikováno v:
Nephrology Dialysis Transplantation. 30:iii297-iii297